NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Stockholders of record on Monday, July 2nd will be paid a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a dividend yield of 3.90%. The ex-dividend date is Friday, June 29th. This is a boost from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health declared that its board has authorized a share repurchase plan on Thursday, February 8th 2018, which permits the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.

Cardinal Health Inc (NYSE:CAH) announced its quarterly earnings data on Thursday, May, 3rd. The company reported $1.39 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.51 by $0.12. The company earned $33.63 billion during the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.42.

15 analysts have issued 1 year price objectives for Cardinal Health's stock. Their predictions range from $40.00 to $81.00. On average, they anticipate Cardinal Health's stock price to reach $64.8571 in the next year. This suggests a possible upside of 32.9% from the stock's current price. View Analyst Ratings for Cardinal Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

News articles about CAH stock have trended somewhat negative recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardinal Health earned a media sentiment score of -0.02 on Accern's scale. They also gave news headlines about the company an impact score of 47.17 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Cardinal Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Hexavest Inc. (0.30%), Deprince Race & Zollo Inc. (0.14%), Bank of Montreal Can (0.09%), Howard Capital Management Inc. (0.07%), Retirement Systems of Alabama (0.05%) and Denali Advisors LLC (0.04%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hexavest Inc., Hartford Investment Management Co., Huntington National Bank, Nippon Life Global Investors Americas Inc., Retirement Systems of Alabama, Nisa Investment Advisors LLC and Riverbridge Partners LLC. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Howard Capital Management Inc., Deprince Race & Zollo Inc., Whittier Trust Co., Cornerstone Wealth Management LLC, State of Alaska Department of Revenue, Regent Investment Management LLC and Kempner Capital Management Inc.. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $48.80.

Cardinal Health has a market capitalization of $15.22 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]